Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis

Cystatin SN, a specific cysteine protease inhibitor, is thought to be involved in various malignant tumors. Therefore, we evaluated the role of cystatin SN in hepatocellular carcinoma (HCC). Notably, cystatin SN was elevated in tumorous samples and cells. Moreover, overexpression of cystatin SN was...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yifeng, Sun, Dan, Song, Ruipeng, Zhang, Shugeng, Liu, Xirui, Wang, Yan, Meng, Fanzheng, Lan, Yaliang, Han, Jihua, Pan, Shangha, Liang, Shuhang, Zhang, Bo, Guo, Hongrui, Liu, Yufeng, Lu, Zhaoyang, Liu, Lianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767558/
https://www.ncbi.nlm.nih.gov/pubmed/31106426
http://dx.doi.org/10.1002/jcp.28828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767558/
https://www.ncbi.nlm.nih.gov/pubmed/31106426
http://dx.doi.org/10.1002/jcp.28828

Ejemplares similares